Evis Bioscience raises €53K Pre-Seed round
25 October 2024· Schlieren, Switzerland· biotech, gene_therapy, drug_delivery, nanotechnology, materials, b2b
To financially support preclinical research until 2027 and allow the team to expand.
Investors
LeadVenture Kick
Also participating
ETH Zurich
About Evis Bioscience
Stage
Seed
Headquarters
Schlieren, Switzerland
Founded
2024
Team Size
6–20
Sectors
biotechgene_therapydrug_deliverynanotechnologymaterialsb2b
Source: https://pitchbook.com/